safety of compounded tirzepatide first-new analyses B12-compounded @EliLillyandCo https://t.co/Dl3jAe9l8h Is Compound Tirzepatide Safe? Key

Blood is more viscous

Harris This is arriving right at the right time

Nicholls, MBBS, PhD, director of the Monash Victorian Heart Institute and professor of cardiology at Monash University in Melbourne, Australia, and colleagues randomly assigned 13,165 participants with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD) to a maximum tolerated dose of 5 mg, 10 mg or 15 mg once-weekly subcutaneous tirzepatide (Mounjaro, Eli Lilly) or 1.5 mg of once-weekly subcutaneous dulaglutide (Trulicity, Eli Lilly) with sham dose escalation

She continues to struggle with health issues, including ongoing blood clots that require extended use of blood thinners